CD38 inhibition protects from high-fat diet-induced obesity via NAD+-dependent SIRT1/PGC-1α signaling (74) and attenuates renal vasoconstriction caused by angiotensin II, ET-1, and norepinephrine (69). Here, CD38 is linked to obesity disorder.